1. Wu, Y., E.J. Benjamin and S. MacMahon, Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China. Circulation, 2016. 133(24): p. 2545-2560.
2. Wilmot KA, O Flaherty M, Capewell S, et al. Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011CLINICAL PERSPECTIVE. Circulation. 2015; 132: 997-1002.
3.Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140: e596-646.
4.Nabel EG. Heart Disease Prevention in Young Women: Sounding an Alarm. Circulation. 2015; 132: 989-91.
5.Gao C, Sun X, Lu L, et al. Prevalence of gestational diabetes mellitus in mainland China: A systematic review and meta‐analysis. J Diabetes Invest. 2019; 10: 154-62.
6.Yan B, Yu Y, Lin M, et al. High, but stable, trend in the prevalence of gestational diabetes mellitus: A population‐based study in Xiamen, China. J Diabetes Invest. 2019; 10: 1358-64.
7.Bellamy L, Casas J, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. The Lancet. 2009; 373: 1773-9.
8.Song C, Lyu Y, Li C, et al. Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women. Obes Rev. 2018; 19: 421-9.
9.Ajala O, Jensen LA, Ryan E, et al. Women with a history of gestational diabetes on long-term follow up have normal vascular function despite more dysglycemia, dyslipidemia and adiposity. Diabetes Res Clin Pr. 2015; 110: 309-14.
10.O'Higgins AC, O'Dwyer V, O'Connor C, et al. Postpartum dyslipidemia in women diagnosed with gestational diabetes mellitus. Irish J Med Sci. 2017; 186: 403-7.
11.Chodick G, Tenne Y, Barer Y, et al. Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study. BMJ Open Diabetes Research & Care. 2020; 8: e870.
12.Retnakaran R, Qi Y, Connelly PW, et al. The Graded Relationship between Glucose Tolerance Status in Pregnancy and Postpartum Levels of Low-Density-Lipoprotein Cholesterol and Apolipoprotein B in Young Women: Implications for Future Cardiovascular Risk. The Journal of Clinical Endocrinology & Metabolism. 2010; 95: 4345-53.
13.Xu Y, Shen S, Sun L, et al. Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis. Plos One. 2014; 9: e87863.
14.Kessous R, Shoham-Vardi I, Pariente G, et al. An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity. England: British Medical Association; 2013. pp. 1118-21.
15.McKenzie-Sampson S, Paradis G, Healy-Profitós J, et al. Gestational diabetes and risk of cardiovascular disease up to 25 years after pregnancy: a retrospective cohort study. Milan: Springer Milan; 2018. pp. 315-22.
16.Shah BR, Retnakaran R, Booth GL. Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus. Diabetes Care. 2008; 31: 1668-9.
17.Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Germany: Springer; 2019. pp. 905-14.
18.Berger H, Gagnon R, Sermer M. Guideline No. 393-Diabetes in Pregnancy. Journal of Obstetrics and Gynaecology Canada. 2019; 41: 1814-25.
19.Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization Guideline. Diabetes Res Clin Pr. 2014; 103: 341-63.
20.Expert Panel On Detection EATO, Expert Panel On Detection EATO. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). United States: American Medical Association; 2001. pp. 2486-97.
21.Alberti KGMM, Zimmet PZ, WHO C. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabetic Med. 1998; 15: 539-53.
22.Prados M, Flores-Le RJ, Benaiges D, et al. Previous Gestational Diabetes Increases Atherogenic Dyslipidemia in Subsequent Pregnancy and Postpartum. Lipids. 2018; 53: 387-92.
23.Herrera Martinez A, Palomares Ortega R, Bahamondes Opazo et al. Hyperlipidemia during gestational diabetes and its relation with maternal and offspring complications. Nutr Hosp. 2018; 35: 698-706.
24.Pletcher MJ, Lazar L, Bibbins-Domingo K, et al. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009; 150: 243-54.
25.Mihaylova B, Emberson J, Blackwell L, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012; 380: 581-90.
26.Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016; 37: 2315-81.
27.Bernstein JA, McCloskey L, Gebel CM, et al. Lost opportunities to prevent early onset type 2 diabetes mellitus after a pregnancy complicated by gestational diabetes. BMJ Open Diabetes Research & Care. 2016; 4: e250.
28.Bernstein JA, Quinn E, Ameli O, et al. Follow-up after gestational diabetes: a fixable gap in women's preventive healthcare. BMJ Open Diabetes Res Care. 2017; 5: e445.
29.Wen C, Metcalfe A, Anderson TJ, et al. Measurement of lipid profiles in the early postpartum period after hypertensive disorders of pregnancy. J Clin Lipidol. 2019; 13: 1008-15.
30.Veerbeek JH, Hermes W, Breimer AY, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension. 2015; 65: 600-6.
31.Joint committee for guideline. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol.2018;15(1):1–29
32.Opoku S, Gan Y, Fu W, et al. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP). BMC Public Health. 2019; 19:1500.
33.Chee C, Shannon CE, Burns A, et al. Relative Contribution of Intramyocellular Lipid to Whole-Body Fat Oxidation Is Reduced With Age but Subsarcolemmal Lipid Accumulation and Insulin Resistance Are Only Associated With Overweight Individuals. Diabetes. 2016; 65: 840-50.
34.Anderson TJ, Gre ́goire J, Pearson GJ, et al.2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol.2016; S0828-282-2.
35.Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidemia: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41: 111-88.
36.Rütti S, Ehses JA, Sibler RA, et al. Low- and High-Density Lipoproteins Modulate Function, Apoptosis, and Proliferation of Primary Human and Murine Pancreatic β-Cells. Endocrinology. 2009; 150: 4521-30.
37.Ma Y, Wang N, Gu L, et al. Postpartum assessment of the beta cell function and insulin resistance for Chinese women with previous gestational diabetes mellitus. Gynecol Endocrinol. 2019; 35: 174-8.